反応式
Br[CH2:2][CH2:3][CH2:4][CH2:5][N:6]1[C:11](=[O:12])[CH2:10][C:9]([CH3:14])([CH3:13])[CH2:8][C:7]1=[O:15].[CH3:16][C:17]([C:20]1[N:21]=[C:22]([N:25]2[CH2:30][CH2:29][NH:28][CH2:27][CH2:26]2)[S:23][CH:24]=1)([CH3:19])[CH3:18].C([O-])([O-])=O.[K+].[K+].Cl>O.C(O)C.CCOCC.CN(C)C=O>[CH3:13][C:9]1([CH3:14])[CH2:10][C:11](=[O:12])[N:6]([CH2:5][CH2:4][CH2:3][CH2:2][N:28]2[CH2:29][CH2:30][N:25]([C:22]3[S:23][CH:24]=[C:20]([C:17]([CH3:19])([CH3:18])[CH3:16])[N:21]=3)[CH2:26][CH2:27]2)[C:7](=[O:15])[CH2:8]1参加物
8
反応物 4
生成物 1
試薬・触媒・溶媒 3
実験手順
4 g 1-(4-Bromobutyl)-4,4-dimethyl-2,6-piperidin-dione, 3.15 g 1-(4-(1,1-dimethylethyl)-2-thiazolyl)-piperazine, 2.7 g K2CO3, 70 ml dimethylformamide and 20 ml water are stirred at room temperature for about 35 hours. The mixture is diluted with water, extracted twice with ether, the combined extracts are washed with water, dried (Na2SO4) and evaporated. The residue is recrystallized from hexane/ethyl acetate, whereby the title compound is obtained, m.p. 93°-94°. M.p. of the hydrochloride is 199°-201° (ethanol/ether).
後処理
- extractionextracted twice with ether
- washthe combined extracts are washed with water
- dry with materialdried (Na2SO4)
- customevaporated
- customThe residue is recrystallized from hexane/ethyl acetate, whereby the title compound
- customis obtained
- customis 199°-201°
出典と根拠
- ORDレコード
- ord-7d9e76ca8dfe499992cc66c682396a9b
- 出典データセット
- uspto-grants-1988_04
- 特許番号
- US04737500
関連ノート
読み込み中…